R&D Projects

RADIOPROLIQ

Molecular signature in liquid biopsy for response to radiotherapy and early relapse in prostate cancer

This project will develop a molecular signature, based on genomics and metabolomics, obtained from liquid biopsies to predict the response to radiotherapy and early relapse in patients with prostate cancer undergoing external radiotherapy (SBRT and IMRT).

Prostate cancer is the second most common cancer among men with 1.28 million cases diagnosed in 2018 worldwide, 88.4% of which were diagnosed in developed countries. It is the sixth leading cause of cancer-related deaths in men, with higher mortality rates in developing countries, and much higher morbidity levels in developed countries thanks to widespread diagnostic methods and early detection. The results obtained in the project will make it possible to predict the response to therapy, as well as to detect early relapse for this type of cancer.

1,28 mill

of cases diagnosed in 2018 worldwide.

detailGrey

Prostate cancer is the second most common cancer among men and the sixth most common cause of cancer-related deaths in men.

In order to achieve the objectives set out in this project, a consortium has been set up to guarantee success in terms of technology and its subsequent commercial exploitation. The project is led by the Recoletas Hospital Network and is supported by the Institute of Biomedical Research of Salamanca (IBSAL), the Medina Foundation, and Atrys Health.

This project has been funded by the Ministry of Science, Innovation, and Universities within the CHALLENGES-COLLABORATION Sub-programme, 2019 Call. The project is co-funded by the European Union with the aim of promoting technological development, innovation, and quality research.

To achieve the objectives

Expediente: RTC2019-007357-1 2020-2023

A consortium has been set up to guarantee success in terms of technology and subsequent commercial exploitation. The project is led by the Recoletas Hospital Network and is supported by the Institute of Biomedical Research of Salamanca (IBSAL), the Medina Foundation, and Atrys Health.

This project has been funded by the Ministry of Science, Innovation, and Universities within the CHALLENGES-COLLABORATION Sub-programme, 2019 Call. The project is co-funded by the European Union with the aim of promoting technological development, innovation, and quality research.

Financial backers

Related projects

eDCardio

eDCardio

Telemedicina para la detección y prevención de enfermedades cardiovasculares

Read more
eDSalud

eDSalud

Plataforma de telemedicina multiespecialidad

Read more
SURVEPROST

SURVEPROST

Firma molecular en biopsia líquida para la vigilancia activa en cáncer de próstata

Read more
PREDIAPT

PREDIAPT

Sistema predictivo para evaluar la respuesta al tratamiento con derivados del platino en cáncer de pulmón

Read more
eHealth

eHealth

Creación de espacios eHealth en hoteles mediante el desarrollo de una plataforma de telemedicina

Read more
iDoctus-Hacking ético

iDoctus-Hacking ético

Plataforma para la detección de enfermedades infecciosas mediante big data y hacking ético

Read more

Would you like to contact the R+D department?

Tell us how we can help you